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Aminoacyl-tRNA synthetases
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Center for RNA Biology, The Ohio State University, Columbus, Ohio 43210, USA
Department of Microbiology, The Ohio State University, Columbus, Ohio 43210, USA
ABSTRACT
The aminoacyl-tRNA synthetases are an essential and universally distributed family of enzymes that plays a critical role in
protein synthesis, pairing tRNAs with their cognate amino acids for decoding mRNAs according to the genetic code.
Synthetases help to ensure accurate translation of the genetic code by using both highly accurate cognate substrate rec-
ognition and stringent proofreading of noncognate products. While alterations in the quality control mechanisms of syn-
thetases are generally detrimental to cellular viability, recent studies suggest that in some instances such changes facilitate
adaption to stress conditions. Beyond their central role in translation, synthetases are also emerging as key players in an
increasing number of other cellular processes, with far-reaching consequences in health and disease. The biochemical ver-
satility of the synthetases has also proven pivotal in efforts to expand the genetic code, further emphasizing thewide-rang-
ing roles of the aminoacyl-tRNA synthetase family in synthetic and natural biology.
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THE AMINOACYL-tRNA SYNTHETASES
Aminoacyl-tRNA synthetases (aaRSs) are universally dis-
tributed enzymes that catalyze the esterification of a
tRNA to its cognate amino acid (i.e., the amino acid corre-
sponding to the anticodon triplet of the tRNA according to
the genetic code) (Ibba and Soll 2000; Pang et al. 2014).
The product of this reaction, an aminoacyl-tRNA (aa-
tRNA), is delivered by elongation factors to the ribosome
to take part in protein synthesis. The discovery of the
aaRSs and their role in protein synthesis began in the 50s
and 60s when it was reported that amino acids were re-
quired to undergo an activation process in order to take
part in protein synthesis (Hoagland 1955; Zamecnik et al.
1958). The discovery of tRNA (Hoagland et al. 1958), the
bridging molecule foretold by Crick in his adaptor hypoth-
esis, led to the identification of the enzymes responsible
for establishing the link between the nucleotide and amino
acid world, the aminoacyl-tRNA synthetases (Hoagland
et al. 1958). AaRSs fulfill two extremely important roles in
translation: not only do they provide the building blocks
for protein synthesis, they are also the only enzymes capa-
ble of implementing the genetic code (Woese et al. 2000;
Banik and Nandi 2012). Aminoacyl-tRNA synthetases are
named after the aminoacyl-tRNA product generated, as
such, methionyl-tRNA synthetase (abbreviated as MetRS)
charges tRNAMet with methionine. In eukaryotes, an alter-
native nomenclature is often used using the one-letter
code of the amino acid (MARS) and a number is added
to refer to the cytosolic (MARS1) or the mitochondrial
(MARS2) variants. A total of 23 aaRSs have been described
so far, one for each of the 20 proteinogenic amino acids
(except for lysine, for which there are two) plus pyrroly-
syl-tRNA synthetase (PylRS) and phosphoseryl-tRNA
synthetase (SepRS), enzymes with a more restricted distri-
bution that are only found in some bacterial and archaeal
genomes (Cusack et al. 1990; Cusack 1995; Arnez and
Moras 1997; Mukai et al. 2017a). It is also worth noting
that in eukaryotes the protein synthesis machineries of mi-
tochondria and chloroplasts generally utilize their own,
bacterial-like sets of synthetases and tRNAs that are dis-
tinct from their cytosolic counterparts (Tzagoloff et al.
1990; Bonnefond et al. 2007).
The aminoacyl-tRNA synthetases catalyze a two-step re-
action that leads to the esterification of an amino acid to
the 3′ end of a tRNA along with the hydrolysis of one mol-
ecule of ATP, yielding aminoacyl-tRNA, AMP, and PPi. In
the first step, termed amino acid activation, both the ami-
no acid and ATP bind to the catalytic site of the enzyme,
triggering a nucleophilic attack of the α-carboxylate oxy-
gen of the amino acid to the α-phosphate group of the
ATP, condensing into aminoacyl-adenylate (aa-AMP),
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which remains bound to the enzyme, and PPi, which is ex-
pelled from the active site (Fig. 1A). Although tRNA is usu-
ally not required for this first step, certain synthetases
(GlnRS, GluRS, ArgRS, and class I LysRS) (Ravel et al.
1965; Mitra and Mehler 1967; Ibba et al. 2001) do require
the tRNA species for productive amino acid activation. In
the second part of the reaction, the hydroxyl group of
the adenine 76 nt attacks the carbonyl carbon of the ade-
nylate, forming aminoacyl-tRNA and AMP (Fig. 1B). While
the two-step aminoacylation reaction is universally con-
served, the aaRSs that catalyze it show extensive structural,
and in some instances functional, diversity as described in
detail below.
Classification of aminoacyl-tRNA synthetases
The 23 known aaRSs can be divided into two major classes
based on the architecture of their active sites (Cusack et al.
1990; Eriani et al. 1990a; Burbaum and Schimmel 1991;
Cusack 1997; Ribas de Pouplana and Schimmel 2001b;
O’Donoghue and Luthey-Schulten 2003). In class I synthe-
tases, the catalytic domain bears a dinucleotide or
Rossman fold (RF) featuring a five-stranded parallel β-sheet
connected by α-helices and is usually located at or near the
amino terminus of the protein. This RF contains the highly
conserved motifs HIGH and KMSKS (Brick et al. 1989;
Rould et al. 1989; Schmidt and Schimmel 1994), separated
by a connecting domain termed connective peptide 1
(CP1) (Starzyk et al. 1987). Class II active site architecture
is organized as seven-stranded β-sheets flanked by α-heli-
ces and features three motifs which show a lesser degree
of conservation than those in class I (Cusack et al. 1990;
Eriani et al. 1990a; Arnez et al. 1995). Both classes also ex-
hibit pronounced differences in their modes of substrate
binding. Class I aaRSs bind the minor groove of the
tRNA acceptor stem (with the exceptions of TrpRS and
TyrRS) and aminoacylate the 2′-OH of the ribose of A76,
while class II approach tRNA from the major groove (Ruff
et al. 1991) and transfer amino acid to the 3′-OH (Sprinzl
and Cramer 1975) (with the exception of PheRS) (Sprinzl
and Cramer 1975; Ruff et al. 1991; Ibba et al. 2001). The
mode of ATP binding is also different between both clas-
ses, being bound in an extended configuration in class I
(Brick and Blow 1987; Brick et al. 1989; Rould et al.
A
B
FIGURE 1. The aminoacylation reaction. In the first step (A), the amino acid (blue) is activated with ATP (red) in the synthetase active site (not de-
picted), forming the aminoacyl-AMP and releasing PPi. (B) The amino acid is transferred to the tRNA (green) and AMP is released (depicted in the
image transfer to the 3′-OH characteristic of class I aaRS, while in class II transfer happens at the 2′-OH with a 3′-OH attack in the second step).
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1989), while class II binds a bent configuration with the
γ-phosphate folding back over the adenine ring (Perona
and Hadd 2012). The kinetics of the aminoacylation reac-
tion can also be used as a distinctive mechanistic signa-
ture, as aminoacyl-tRNA release is the rate limiting step
for class I enzymes (except for IleRS and someGluRS) while
for class II it is the amino acid activation rate instead (Fersht
1977; Perona et al. 1991; Kaminska et al. 2001).
Class I and II can be further divided into different sub-
groups based upon phylogenetic analysis, comparison of
structural and mechanical characteristics and domain
organization (Table 1). Although there is consensus in the
division of class II synthetases into three subgroups (a, b,
and c), the classification of class I is more complex, with
some authors classifying them into three subgroups
(Cusack 1995; Ribas de Pouplana and Schimmel 2001b;
First 2005) while others propose up to five subclasses
(Perona and Hadd 2012; Valencia-Sánchez et al. 2016).
Interesting relations between the aaRSs and their amino
acid substrates emerge when considering the grouping
into subclasses. For example, subclass Ia recognizes ali-
phatic amino acids such as Leu, Ile, and Val and thiolated
amino acids such as Met and Cys, while class Ic aaRSs acti-
vate the aromatic amino acids Tyr and Trp. Interestingly,
similar correlations exist within the class II enzymes. For ex-
ample, class Ib enzymes activate charged amino acids such
as Lys, Glu, and Gln, while their class IIb counterparts acti-
vate Lys, Asp, and Asn, also polar amino acids.
The structural diversification of the aaRSs can be corre-
lated both with the recognition of structurally and chemi-
cally diverse cognate substrates, and with the need to
exclude near- and noncognate amino acids. To prevent
the use of mischarged tRNAs in protein synthesis, some
synthetases have evolved editing activities that specifically
target and hydrolyze misactivaed amino acids and/or mis-
acylated tRNAs. The editing activity may reside in the cat-
alytic site, in separate domains or even in freestanding
separate proteins. In class I synthetases, the editing activity
is usually located in the connecting peptide CP1 while in
class II this activity can be located in different domains
(Schmidt and Schimmel 1994, 1995; Lin and Schimmel
1996; Giege et al. 1998; Nureki et al. 1998; Dock-
Bregeon et al. 2000). The editing domains andmechanism
used will be discussed in detail below.
TABLE 1. Classification of the synthetases into two classes, along with the quaternary structure and the presence of editing activity (and
amino acids against which they display editing activity in parenthesis)
CLASS I CLASS II
Structure Editing (target) Structure Editing (target)
Subclass a MetRS α2 Yes (Hcy, Thl) SerRS α2 Yes (Thr, Cys, SerHX)
ValRS α Yes (Thr, Abu, Cys,
Ala, Hcy)
ThrRS α2 Yes (Ser)
LeuRS α Yes (Nva, Ile, γhL,
δhL, γhI, Met)
AlaRS α2 Yes (Ser, Gly)
IleRS α Yes (Val, Cys, Hcy,
Thr, Abu)
GlyRS α2, (αβ)2 No
CysRS α, α2 ProRS α2 Yes (Ala, Cys)
ArgRS α2 HisRS α2 No
Subclass b GluRS α AspRS α2 No
GlnRS α AsnRS α2 No
LysRS-I α LysRS-II α2 Yes (Orn, Hcy, Hse)
Subclass c TyrRS α PheRS (αβ)2, α Yes (Tyr, Ile)
TrpRS α2 PylRS α2 No
SepRS α4 No




Minor groove approach to
tRNA
Major groove approach to
tRNA
Transfer amino acid to the
3′-OH
Transfer amino acid to the
2′-OH
Bind ATP in an extended
configuration
Bind ATP in a bent
configuration
aa-tRNA release is the
limiting step
Amino acid activation is the
limiting step
Hcy, homocysteine; Nva, norvaline, 4hP, 4-hydroxyproline; Thl, homocysteine thiolactone; SerHX, serine hydroxamate; Orn, ornithine; Hse, homoserine; γhL,
γ-hydroxyleucine; δhL, δ-hydroxyleucine; γhI, γ-hydroxyisoleucine; δhI, δ-hydroxyisoleucine; Abu, α-aminobutyrate.
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Origin and evolution of aaRSs
AaRSs are believed to have originated very early in evolu-
tion and it is thought that an almost complete set was al-
ready present within the last universal common ancestor
(LUCA) (Nagel and Doolittle 1995; Woese et al. 2000;
Fournier et al. 2011). The aminoacyl-tRNA synthetases
are a unique family of proteinaceous enzymes, as they
are the only proteins that are able to decode the rules of
the genetic code, all while being translated following
those same rules. This apparent dilemma has made
unveiling the evolutionary origin of synthetases particularly
intriguing. As mentioned above, both classes of synthetas-
es approach the tRNA fromdifferent sides and it is possible
to simultaneously model the docking of pairs of enzymes
of each class to a single tRNA without major steric hin-
drances (Ribas de Pouplana and Schimmel 2001b). This
complementary recognition of the major and minor
grooves of the tRNA acceptor stem is the basis of a pro-
posed evolutionary model in which both ancestors of
each class arose form a single gene. Under this scenario,
usually known as the Rodin–Ohno hypothesis, the gene
of the ancestral aminoacyl-tRNA syntethase could be
read bidirectionally, and each of the opposite strands
would code for the ancestor of class I and class II, respec-
tively. Both would be able to interact with the tRNA mole-
cule and charge it with different amino acids. Although
only an extremely simplified genetic code could be sus-
tained with these two enzymes, subsequent events of
gene duplication would configure the set of synthases as
it is known today (Rodin and Ohno 1995; Kunst et al.
1997; Carter and Duax 2002; Rodin et al. 2009; Martinez-
Rodriguez et al. 2015). As the study of the evolution of
aaRSs involves exploring scenarios before the LUCA, ex-
perimental research is often challenging. One useful strat-
egy is to compare enzyme anatomy by superposing
tridimensional models aiming at unveiling the most basic
functional and invariant core of the enzyme. This extremely
reduced version of an aaRS has been termed an urzyme
(“ur”meaning primitive, original, earliest) and usually com-
prises the amino acid activation and acyl-transfer active
sites of the full-length enzyme. Despite containing only
slightly more than a hundred amino acids, urzymes still re-
tain the basic catalytic capabilities of the synthetase
(Augustine and Francklyn 1997; Pham et al. 2010; Carter
2017; Carter and Wills 2019). For example, a 130 amino
acid long tryptophanyl-tRNA synthetase urzyme has
been shown to accelerate Trp activation 109-fold (com-
pared to the spontaneous activation rate) (Pham et al.
2007) and similar results have been achieved with HisRS
(Li et al. 2011). Regarding selectivity, these ancestral
urzymes would operate on an extremely basic code,
each class favoring hydrophobic, or hydrophilic amino ac-
ids rather than specific ones. This binary codewould create
the hydrophobic cores and solvent interfaces of the pri-
mordial globular proteins (Pham et al. 2007). After their
original inception, subsequent duplication, specialization,
and domain acquisitions events would complete the actual
set of synthetases (Rodin and Ohno 1995; Augustine and
Francklyn 1997; Woese et al. 2000; O’Donoghue and
Luthey-Schulten 2003).
Organisms with incomplete sets of aaRSs
As proteins are made of 20 L-amino acids, it would be ex-
pected for every organism to have a complete set of 20
aaRSs and, consistent with this, mutations in synthetase
genes often lead to diseases if not lethality. Surprisingly,
complete genome analysis has found numerous instances,
especially among bacterial and archaeal genomes, in
which ORFs encoding for synthetases are missing
(Bult et al. 1996; Kunst et al. 1997; Smith et al. 1997;
Cathopoulis et al. 2007). GlnRS is the most common ab-
sence in the synthetase set, being absent in archaeal ge-
nomes and often missing from many bacteria and
eukaryotic organelles. Another aaRS often missing is
AsnRS. These organisms accomplish the charging of
tRNAAsn and tRNAGln via an indirect two-step route that in-
volves a nondiscriminating (ND) synthetase and an amido-
transferase (AdT) complex (Fig. 2A). In the first step, a
nondiscriminating Asp or GluRS incorrectly charges the
tRNA producing Asp-tRNAAsn or Glu-tRNAGln (Wilcox
1969; Lapointe et al. 1986; Schön et al. 1988; Curnow
et al. 1996). The misacylated tRNA is the substrate of an
amidotransferase complex that catalyzes the transamida-
tionof the amino acidusingATPandan aminogroupdonor
fromglutamine (Curnowet al. 1997; Raczniaket al. 2001). In
order to prevent mistranslation of Asn or Gln codons, the
product of these ND-aaRSs must not be liberated before
reaching the amidotransferase. This goal is achieved by
forming a complex with the adT, the synthetase and the
tRNA termed the transamidosome, that channels the ami-
noacyl-tRNA directly to the AdT (Bailly et al. 2007;
Rathnayake et al. 2017). To ensure accurate decoding
and avoid relying on a ND synthetase, some bacteria use
a set of duplicatedenzymes. For example,Helicobacter py-
lori has a set of two GluRS: GluRS1 is a discriminating en-
zyme used for decoding Glu codons while GluRS2, its
nondiscriminating counterpart, is used for indirect synthe-
sis of tRNAGln (Salazar et al. 2003; Skouloubris et al.
2003). This complementarity of functions ensures an accu-
rate decoding of the genetic message.
The AdT complex in Bacteria is made up of three pro-
teins called GatCAB while in some mitochondria the sub-
unit GatC is replaced by the longer GatF (Araiso et al.
2014). In archaeal genomes, the Adt is composed of a tet-
ramer made by GatDE (Tumbula et al. 2000; Feng et al.
2004). Interestingly, phylogenetic analyses of bacterial ge-
nomes that contain GlnRS suggest a eukaryotic origin and
posterior acquisition by bacterial phyla via horizontal gene
Aminoacyl-tRNA synthetases
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transfer (Lamour et al. 1994; Brown and Doolittle 1999). In
some organisms, the biosynthetic genes for Asn or Gln are
missing, as in the case of S. aureus, that lacks genes for as-
paragine biosynthesis and relies on an ND-AspRS and the
indirect route to synthetize this amino acid on the tRNA
(Mladenova et al. 2014). It has been proposed that a
bona fide GlnRS and AsnRS emerged in a eukaryotic
post-LUCA environment, suggesting Asn and Gln to be
late additions to the genetic code (Ribas de Pouplana
and Schimmel 2001a).
Some methanogenic archaea lack the CysRS gene and
use an indirect route for charging tRNACys (Tumbula
et al. 1999). This route relies on a noncanonical class II
aaRS, termed o-phosphoseryl-tRNA synthetase (SepRS)
that charges tRNACys with the nonproteinogenic amino
acid o-phosphoserine (Sauerwald et al. 2005). The o-phos-
phoseryl-tRNACys intermediate is then further modified by
Cys-tRNA synthase (SepCysS) into cysteine (Fig. 2B;
Sauerwald et al. 2005; Mukai et al. 2017a). In some meth-
anogenic archaea, such as Methanocaldococcus janna-
schii, Methanothermobacter thermautotrophicus, and
Methanopyrus kandleri, the cysE ORF encoding for one
of the genes for cysteine biosynthesis is missing and the
mechanism described above seems to be the only route
available for cysteine biosynthesis (Ambrogelly et al.




LysRS is the only synthetase known
to date with representatives in both
structural classes. Class II LysRS is the
most abundant form, present in most
organisms, while the class I LysRS is
found mostly in archaea and some
bacteria, apparently as a result of hor-
izontal gene transfer (Eriani et al.
1990b; Ibba et al. 1997b). Although
only one class of LysRS is found in
most organisms,Methanosarcinaceae
archaea and some other isolated spe-
cies such asNitrosococcus oceani and
Bacillus cereus have both classes (Pol-
ycarpo et al. 2003). Structures for both
forms have been resolved and shown
to use similar mechanisms for sub-
strate recognition and even recognize
the same tRNA determinants (Terada
et al. 2002). Phylogenetic analyses
show that both enzymes have a differ-
ent evolutionary origin and are usually
presented as an example of conver-
gent evolution (Ibba et al. 1997a).
GlyRS
Another example of duplicated synthetases that present
two isoforms of different origin is GlyRS. The most com-
mon form in bacteria is a tetramer (α2β2) that is classified
as IIc, while archaea, eukaryotes and some bacteria pos-
sess a dimeric form (α2) classified as IIa (Freist et al. 1996;
O’Donoghue and Luthey-Schulten 2003; Perona and
Hadd 2012). Although both forms share the characteristic
active site for class II synthetases, the other structural ele-
ments of this domain are different for the two forms, the
most striking difference being the amino acid recognition
pocket. In the dimeric GlyRS, the amino acid is recognized
by three negatively charged conserved residues while the
bacterial enzyme (α2β2) uses five different conserved resi-
dues that creates a much less polar environment than its
dimeric counterpart (Valencia-Sánchez et al. 2016). The
case of GlyRS presents a slightly different scenario than
the example of LysRS covered above, as both forms
descend from the ancestral class II synthetase enzyme.
The simple hypothesis that both GlyRS forms arose from
a common pre-GlyRS is highly unlikely, due to the afore-
mentioned differences in the amino acid recognition resi-
dues, as well as other differences in motif 2 of the bacterial
tetrameric enzyme that are not sharedwith any other of the




FIGURE 2. Indirect aminoacylation pathways. (A) Asn and Gln. tRNAAsn is mysaspartylated by
aND-AspRS. The resultant Asp-tRNAAsn is converted to Asn-tRNAAsn by the glutamine-depen-
dent amidotransferase (AdT). The process is similar for Gln-tRNAGln. (B) Cysteine. tRNACys is
charged with O-phosphoserine by dedicated synthetases and further modified to cysteine
by SepCysS to yield Cys-tRNACys. (C ) Selenocysteine. SelA (Bacteria) or PSTK followed by
Sep-tRNA:Sec-tRNA synthase (Archaea and Eukarya) modify a previously charged
SertRNASec from serine to selenocysteine.
Rubio Gomez and Ibba
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core presents the same differences as the tetrameric GlyRS
(namely a highly conserved Glu residue in motif 2 is
changed to Asp in AlaRS and GlyRS and a conserved Trp
is involved in amino acid recognition), and their active sites
share similar overall architectures. This observation led to
the proposal that the dimeric form evolved from the ances-
tral class II enzyme while the tetrameric GlyRS evolved
from either AlaRS or an ancestor of AlaRS that was able
to aminoacylate both Ala andGly. Due to this intimate evo-
lutionary relationship and the shared similarities, some au-
thors have proposed tetrameric GlyRS and AlaRS to be
grouped in a different subclass, IId (Valencia-Sánchez
et al. 2016).
Expanding the set of 20 aaRSs
Selenocysteine
More than 140 different amino acids have been identified
in naturally occurring proteins, although outside of the 20
proteinogenic ones nearly all of them are the result of post-
translation modifications (Uy and Wold 1977; Macek et al.
2019). There are only two known exceptions that are spe-
cifically decoded during protein synthesis, the noncanon-
ical selenocysteine and pyrrolysine. Selenocysteine was
the first noncanonical amino acid discovered outside the
original 20 amino acids of the genetic code (Cone et al.
1976; Hatfield et al. 1982). Structurally, it is similar to cyste-
ine except that the thiol group is replaced by a selenol
group. Selenocysteine is often found at the active site of
proteins involved in redox reactions, where the lower re-
dox potential of the selenium compared to sulfur proves
to be beneficial (Johansson et al. 2004; Reich and
Hondal 2016). No SecRS enzyme has been identified to
date and an indirect charging mechanism, similar to that
of AsnRS and GlnRS mentioned above, is used instead,
where selenocysteine is formed from serine already
charged on the tRNASec (Lee et al. 1989). This process is
carried out by selenocysteine synthase (SelA) in bacteria
(Leinfelder et al. 1988; Forchhammer et al. 1991) and o-
phosphoseryl-tRNA kinase (PSTK) followed by Sep-tRNA:
Sec-tRNA synthase in archaea and eukarya (Fig. 2C;
Carlson et al. 2004; Kaiser et al. 2005; Yuan et al. 2006).
Another atypical aspect of selenocysteine incorporation
is the absence of an assigned sense codon in the genetic
code. For selenocysteine, incorporation occurs at UGA
stop codons (Chambers et al. 1986; Lee et al. 1989) iden-
tified by a nearby cis element termed SECIS (for selenocys-
teine insertion sequence) (Liu et al. 1998), a stem–loop
structure in the mRNA (bacteria) (Zinoni et al. 1990;
Heider et al. 1992; Chen et al. 1993) or a structure in the
3′ untranslated region, far removed from the UGA codon,
in archaea and eukaryotes (Zinoni et al. 1990; Berry et al.
1991, 1993). Sec-tRNASec is then delivered to the ribosome
by specialized elongation factors SelB in bacteria (Rasubala
et al. 2005; Yoshizawa et al. 2005) and eEFSec alongside
protein cofactors in archaea and eukaryotes (Berry et al.
1993; Fagegaltier 2000; Tujebajeva et al. 2000).
Pyrrolysine
Pyrrolysine (Pyl) is the other known addition to the stan-
dard code of 20 amino acids and the most recent, being
identified in 2002 (Srinivasan et al. 2002; Soares et al.
2005). Pyrrolysine was first reported in some genera of
methanogenic archaea from the Methanosarcina family,
which produce Pyl-containing methyltransferases that al-
low the methylation of coenzyme M, the penultimate
step in the formation of methane from methylamines
(DiMarco et al. 1990). As in the case of selenocysteine,
the special chemical properties of pyrrolysine are used in
the methyltransferase active site, via a proposed methyl-
ammonium adduct that activates methylamines (Krzycki
2004). Unlike selenocysteine, pyrrolysine exists as a free
metabolite and is biosynthesized by three enzymes (PylB,
C and D) and it is charged by its unique synthetase, pyrro-
lysyl-tRNA synthetase, PylS, directly onto the tRNAPyl
(Blight et al. 2004). Based upon the structure of its catalytic
core, PylRS is classified as a Class II enzyme, although it
possesses a unique mechanism of tRNA recognition.
tRNAPyl itself has several unusual characteristics, such as
shortened variable loop containing only three nucleotides
instead of the more common five, an extended acceptor
stem with six instead of five nucleotides or a reduced link-
age between the acceptor and stem and the D-loop, con-
sisting of only one base rather than the regular two found
in other tRNAs (Ueda et al. 1992; Soma and Himeno 1998;
Srinivasan et al. 2002). Upon binding tRNA, PylRS does not
recognize the anticodon as an identity element but the ad-
jacent bases instead. Similar to the case of selenocysteine,
Pyl-tRNAPyl is cotranslationally inserted via specific amber
UAG stop codons but unlike selenocysteine, Pyl-tRNAPyl is
efficiently recognized by elogantion factor Tu and does
not require any accessory factors (Krzycki 2004). It was
also reported that the Pyl-containing methyltransferases
from the Methanosarcina family contain a conserved se-
quence immediately 3′ of the UAG codon, predicted to
form a stem–loop. It has been proposed that this se-
quence, termed the pyrrolysine incorporation sequence
(PYLIS) (Namy et al. 2004; Théobald-Dietrich et al. 2005),
would function as a contextual element for Pyl insertion,
similar to the SECIS element for selenocysteine. It has
also been reported that Pyl incorporation can occur in
the absence of the PYLIS motif (Polycarpo et al. 2006;
Longstaff et al. 2007), although it has been proposed
that this effect is a consequence of codon supression, as
Pyl-tRNAPyl can bind EF-Tu (Théobald-Dietrich et al.
2004). Since its discovery in methanogenic archaea, genes
encoding PylRS have also been found in some bacteria, al-
though in the latter the enzyme is coded by two genes
Aminoacyl-tRNA synthetases
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pylSn (encoding for the N-terminal domain) and pylSc (en-
coding the carboxy-terminal domain). The restricted distri-
bution of PylRS makes it difficult to ascertain the
evolutionary history of the enzyme, although it has been
proposed that PylRS arose in a pre-LUCA environment
(Fournier et al. 2011) and later disseminated through hor-
izontal gene transfer (Krzycki 2004; Fournier 2009;
Fournier et al. 2011).
TRANSLATION FIDELITY AND QUALITY CONTROL
tRNA recognition
In order to ensure the faithful translation of the genetic
message, synthetases must identify and pair particular
tRNAs with their cognate amino acid which relies on the
proper recognition of both substrates. This can prove ex-
tremely challenging for the synthetases as not only have
they to discriminate the correct tRNA isoacceptor among
a set of other tRNAs very similar in structure and chemical
composition but also be able to select the cognate amino
acid amidst an extremely large pool of similar amino acids,
both proteinogenic and nonproteinogenic. The evolution-
ary pressure to maintain fidelity has driven aaRSs to
develop an elevated specificity for their substrates, both
the tRNA and the amino acid, although in some cases
this specificity is tailored to particular environments of or-
ganisms or the properties of individual cellular compart-
ments (Reynolds et al. 2010b; Yadavalli and Ibba 2012a).
Through various structural and presteady state kinetic
studies, a general model for tRNA binding has been eluci-
dated (Beuning and Musier-Forsyth 1999). The first stage
of tRNA binding is relatively fast and unspecific, driven
mainly by the electrostatic interactions between positively
charged residues of the proteins and the phosphate back-
bone of the tRNA (Tworowski et al. 2005; Perona and Hou
2007). Although the general cloverleaf structure is shared
by all tRNAs, subtle differences in shape and conformation
arise from sequence-dependent effects. These small dif-
ferences in structure, charge distribution and base stacking
allow for a first indirect readout of the phosphate and sugar
backbone of tRNA by the synthetase, increase affinity of
the enzyme for its cognate substrate and may provide a
reason as to why the tRNA sequence is so heavily con-
served, as even bases that do not directly interact with res-
idues in the synthetase contribute nevertheless to this
indirect readout (Perona and Hou 2007). After this initial
phase, more specific contacts are made and the tRNA un-
dergoes a slower conformational change during accom-
modation within the catalytic site. Differential binding
affinity is not sufficient to ensure the correct recognition
of the cognate tRNA and therefore kinetic discrimination
is used to overcome these limitations and help the aaRS
distinguish between cognate and noncognate tRNAs.
Aminoacylation of the correct tRNA is influenced more
by kcat effects than by KM effects (Ebel et al. 1973).
Proper recognition of the cognate tRNA issoaceptor is
aided by identity elements which are certain nucleotides
(in some instances modified) or structural elements, al-
though their nature is idiosyncratic to each pair of synthe-
tase and tRNA. These elements are called identity
determinants if they promote the binding of the cognate
tRNAoranti-determinants if they induce releaseof thenon-
cognate tRNA and are usually located in the anticodon
stem or in the acceptor arm (Kim and Quigley 1979;
Normanly et al. 1992; Giege et al. 1998; Larkin et al.
2002; Pereira et al. 2018; Jordan Ontiveros et al. 2019).
One major recognition element are bases 35, 36, and 37
of the anticodon stem–loop, usually heavily modified
(Muramatsu et al. 1988; Perret et al. 1990; Pütz et al.
1994), as well as base 73 in the acceptor stem (Crothers
et al. 1972; Giege et al. 1998; Paris et al. 2012). Because
some amino acids are decoded by as many as six codons,
some tRNAs that encode for the same amino acid may
not share any nucleotide of the anticodon, which renders
recognition difficult for the synthetase. Two examples are
LeuRS and SerRS that have evolved alternative recognition
mechanics to circumvent this issue. In the caseof SerRS, the
long variable arm of tRNASer functions as an important dis-
crimination element (Park and Schimmel 1988; Dock-
Bregeon et al. 1990b; Asahara et al. 1993). One of the
best studied examples of tRNA recognition is tRNAAla,
where recognition is exclusively based on a G3-U70 base
pair (Hou and Schimmel 1988; McClain and Foss 1988).
This base pair marks tRNA to be charged by AlaRS and is
highly conserved, with the exact recognition mechanism
varying between the three domains of life (Chong et al.
2018). This determinant is so robust that artificially trans-
planting this pair into other tRNAs triggers aminoacylation
byAlaRS, both in vitro and in vivo (Hou andSchimmel 1988;
McClain and Foss 1988; Francklyn and Schimmel 1989).
Amino acid recognition
Recognition of the cognate amino acid poses a different
challenge to tRNA, as amino acids are small molecules, of-
ten with similar physicochemical properties, making dis-
crimination harder due to the limited number of contacts
made between the substrate and the enzyme. To maintain
accurate decoding, synthetases use a variety of strategies
to discriminate against noncognate amino acids, such as
exclusion via size, charge or use of metal ions that bind
specific chemical groups. The PheRS synthetic active site
harbors a conserved Ala residue that helps determine spe-
cificity for phenylalanine over tyrosine, althoughmitochon-
drial human and yeast PheRS lack this critical residue and
rely on a higher specificity for cognate substrate to discrim-
inate against the noncognate (Reynolds et al. 2010b;
Bullwinkle et al. 2014a). Another well-studied example is
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recognition of glycine, the smallest amino acid which also
lacks a side chain. The GlyRS active site is a highly nega-
tively charged pocket, while one serine residue (eukaryot-
ic) or two threonine residues (bacterial) prevent activation
of any other amino acids larger than glycine (Valencia-
Sánchez et al. 2016). Some aaRSs use coordinated metal
ions in the active site to discriminate the cognate amino
acid. Crystallographic studies in E. coli ThrRS have re-
vealed the presence of a zinc atom within the active site,
which plays an essential role in discriminating against
the noncognate valine. The zinc atom is complexed with
two residues of histidine, one residue of cysteine and
a molecule of water into a tetrahedral coordination
(Sankaranarayanan et al. 1999). Upon binding of threonine,
the water molecule is displaced, and the zinc coordination
changes from the tetrahedral to a square-based pyramidal
pentacoordination state, stabilized by the amino and hy-
droxyl groups of threonine. The methyl group present in
valine is unable to trigger this coordination change and
is hence not activated by ThrRS (Sankaranarayanan et al.
2000). A similar mechanism is used by CysRS to discrimi-
nate against serine, in which a zinc atom within the active
site establishes a tight thiol coordination with the cognate
serine. This zinc-based recognition mechanism is so strin-
gent that, as opposed to ThrRS, an editing activity is not
required for maintaining accuracy in charging tRNACys
(Zhang et al. 2003). Similarly, the SerRS of methanogenic
archaea possess a zinc ion tetra-coordinated by Cys and
Glu residues and a molecule of water, which is displaced
upon serine binding. Modeling threonine in the same ori-
entation as serine onto the active site would induce clashes
between the threoninemethyl group and the Cys residues,
forcing threonine into a less productive conformation for
activation (Bilokapic et al. 2006, 2008).
AaRSs and translational quality control
Faithful translation of the genetic message is paramount
for the accurate synthesis of proteins and to prevent the in-
troduction of mutations often associated with loss of func-
tion and disease. Gene expression is a complex process
involving several steps from DNA replication, to transcrip-
tion and finally translation, which use different strategies to
maintain accuracy. The robust prevention, correction and
repair activities of DNA polymerase keeps errors in replica-
tion at a low frequency of 1 per 10−8, while the proof-read-
ing mechanisms of RNA polymerase allow a transcription
error rate of about 1 in 10−5. The misincorporation of ami-
no acids into a polypeptide chain at the ribosome accounts
for most missense errors during translation, with some
studies reporting estimates as high as 103–104 per amino
acid site (Loftfield and Vanderjagt 1972; Ibba et al.
1997a). At this error rate, 15% of average-length proteins
will contain an amino acid mismatch, which may be further
increased under stress conditions such as starvation, viral
infection or oxidative stress (Gomes et al. 2007; Netzer
et al. 2009; Lant et al. 2018). This relatively low accuracy
during protein synthesis at the ribosome is the result of
two different events: mismatching of the mRNA:tRNA du-
plex and mischarging of the tRNA with a near- or noncog-
nate amino acid. Faithful translation of an mRNA relies on
accurate pairing of the codon–anticodon duplex via
Watson–Crick interactions at the decoding center, buried
deep within the ribosome. The tight grip that the decod-
ing center exerts over themRNA-duplex influences the sta-
bilization of uncommon tautomeric forms of the
nucleotides matching the dimensions of canonical
Watson–Crick pairs, allowing formation of G–U pairs and
subsequent introduction of mismatches in the resulting
polypeptide (Rozov et al. 2015) and translation speed influ-
ences the occurrence of codon–anticodonmispairing, with
more errors appearing at sites where ribosome velocity is
higher (Mordret et al. 2019). Elongation factors also con-
tribute to accurate decoding by selectively binding cog-
nate aminoacyl-tRNAs. The binding of the elongation
factor is thermodynamically tuned to bind the correct
pair of amino acid:tRNA, while the decreased affinity for
the noncognate pair may lead to premature release, and
spontaneous hydrolysis, of the mischarged tRNA
(LaRiviere et al. 2001; Blanchard et al. 2004; Gromadski
and Rodnina 2004; Loveland et al. 2017). Nevertheless,
while elongation factors contribute to fidelity, accurate
protein synthesis is highly reliant on the availability of ami-
noacyl-tRNAs harboring the cognate amino acid, placing
aaRSs as key players in maintaining fidelity (Mordret
et al. 2019). The proofreading mechanisms used by
aaRSs to ensure cognate aa-tRNAs are provided for trans-
lation are collectively referred to as “editing,” and are de-
scribed in more detail below.
Editing mechanisms in aaRSs
Despite the high affinity of aaRSs for their substrates, non-
cognate amino acids are sometimes activated and charged
onto tRNAs, producing misacylated tRNAs that may, upon
reaching the ribosome, be used in protein synthesis. In
1957, Linus Pauling estimated the misactivation rate about
1 in 200 from a theoretical standpoint (Pauling 1958), al-
though later experiments by Loftfield (Loftfield and
Vanderjagt 1972) showed the in vivo misincorporation
rate to be closer to 1 in 3000. These results suggested
the presence of some sort of proof-reading accounting
for the difference before predicted and observed out-
comes. These results led Fersht to propose a “double
sieve” model in which the active site was a first sieve,
able to exclude non cognate amino acid. Complementary
to this was a second site, responsible for clearing the acti-
vated amino acid that surpassed the first filter, that pos-
sessed hydrolytic activity to clear the misacylated
products that escape the first sieve (Fersht 1977). The
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existence of a separated editing site was described for the
first time in class I IleRS (Baldwin andBerg 1966) and later in
ValRS (Starzyk et al. 1987), where it is located in the CP1
domain and is responsible for clearing Val-tRNAIle and
Thr-tRNAVal, respectively. To date, editing activity has
been described in 10 out of the 23 aaRSs. In class I synthe-
tases, this activity is located in the highly conserved CP1
domain, although in some enzymes such as MetRS the ed-
iting activity resides in the catalytic site (Nureki et al. 1998;
Fukai et al. 2000). In class II synthetases, however, the edit-
ing domains are more idiosyncratic. Editing mechanisms
can be divided in two categories: pre- or post-transfer ed-
iting, in regard to the editing taking place before or after
the transfer of the amino acid to the tRNA (Fig. 3). Some
aaRSs, such as ValRS and LeuRS, present both editing
mechanisms (Nureki et al. 1998), but use one of them pref-
erentially. Preferences on one of the two routes is also or-
ganism-dependent. E. coli LeuRS exclusively uses post-
transfer editing while S. cerevisiae LeuRS predominantly
uses the pretransfer activity (Mascarenhas et al. 2008).
The use of either route is largely defined by the relative
rates of aminoacyl adenylate hydrolysis and transfer to
the tRNA. In systems such as ValRS, with a transfer rate
around 200 times higher than hydrolysis, post-transfer ed-
iting is heavily favored (Fersht 1977; Dulic et al. 2010),
whereas in enzymes where both rates are roughly equal,
such as IleRS, both pathways contribute to clearing the
noncognate product (Dulic et al. 2010; Minajigi and
Francklyn 2010).
Pretransfer editing
Pretransfer editing has been described in both class I and
class II aaRSs and takes place after aa-AMP synthesis but
before the aminoacyl moiety is transferred to the tRNA.
Although the tRNA does not participate in the reaction it-
self, it has been reported that tRNA binding promotes ed-
iting activity in some aaRSs and is a requirement in IleRS
and LeuRS (Baldwin and Berg 1966; Boniecki et al. 2008;
Yadavalli et al. 2008). Pretransfer editing can follow two
main pathways. The first one is the selective release of
the aa-AMP to the cytosol, where the labile phosphoesther
bond is spontaneously hydrolyzed. The second route in-
volves the enzymatic breakdown of the product and may
happen either in the active site or in an independent edit-
ing site. Homocysteine, homoserine and ornithine are
FIGURE 3. The editing pathways. Schematic overview of the editing pathways used by the synthetases. In the figure above, the events are in
italics, while the editing paths are in bold. The pathways are divided between pretransfer and posttransfer pathways. In the pretransfer editing,
the activated noncognate aminoacyl-adenylatemay be released from the enzyme and hydrolyze spontaneously or be edited within the active site
or a specialized active site. Upon transfer to the tRNA, the aminoacyl-tRNA can be translocated to the editing site or released and cleared by a
dedicated trans-editing factor. The cognate aminoacyl-tRNA binds the elongation factors and proceeds to translation in the ribosome.
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thiolated non proteinogenic amino acids that are routinely
edited by several synthetases (MetRS, LysRS, and ValRS)
via pretransfer editing activity located at the active site
(Jakubowski 1991, 1994, 1999b). The architecture of the
active site of MetRS partitions the substrates toward the
aminoacylation or editing routes by establishing interac-
tion with the side chain. In the case of the cognate methi-
onine, the methyl side chain is stabilized with tryptophan
and tyrosine residues and proceeds to aminoacylation. In
contrast, homocysteine lacks this methyl side chain and in-
teracts with an aspartate residue in the thiol subsite of the
active site. This conformation triggers an intramolecular
cyclization mechanism that produces homocysteine thio-
lactone, which is then expelled from the active site
(Fersht and Dingwall 1979; Jakubowski 1991). Class II
LysRS uses a similar mechanism for editing of homocyste-
ine, homoserine and ornithine into homocysteine thiolac-
tone, lactone and lactame, respectively (Jakubowski
1999a).
Post-transfer editing
Post-transfer editing takes place after the transfer of the
amino acid to the tRNA and involves the hydrolysis of
the ester bond, in a domain separated from the active
site. The specific mechanism of editing is idiosyncratic to
each synthetase but in general, once formed the aa-
tRNA triggers a conformational change and the 3′ terminus
containing the aa is translocated from the active site to the
editing site, sometimes traversing distances as large as 40
Å (Silvian et al. 1999; Arnez et al. 2000; Fukai et al. 2000;
Dock-Bregeon et al. 2004; Palencia et al. 2012). As the
core of the tRNA remains bound to the enzyme, this trans-
location often involves a rearrangement of the 3′ terminus
to relocate to the editing site. In class I synthetases, the
CCA sequence of the tRNA adopts a hairpin conformation
to enter the active site (Cusack 1997; Nureki et al. 1998),
but must extend in order to reach the editing site while
in class II synthetases, in a mirror fashion, the CCA shifts
from an extended conformation at the synthetic site to a
bent conformation to enter the editing site (Arnez et al.
2000; Dock-Bregeon et al. 2000). In class I synthetases
with post-transfer editing activity, LeuRS, IleRS, and
ValRS, this activity in confined to the CP1 domain while
in class II synthetases these domains are more idiosyncrat-
ic. For example, AlaRS presents an editing domain at the
carboxyl terminus while in bacterial ThrRS, a homologous
domain is located in the amino terminus. This analogy be-
tween ThrRS and AlaRS illustrates once more that aaRSs
are built by attaching different functional modules to the
catalytic core (Sankaranarayanan et al. 1999). For ThrRS
in archaea the amino-terminal editing domain is homolo-
gous to a family of enzymes called D-aminoacyl-tRNA-
deacylases (DTDs) (Dock-Bregeon et al. 2000; Hussain
et al. 2006), while in the heterotetrameric PheRS the edit-
ing domain is located in the β-subunit (Roy et al. 2004) and
the catalytic activity is located in the α-subunit (Mosyak
et al. 1995; Fishman et al. 2001). All these examples help
in illustrating the diversity of mechanisms that have
evolved to ensure accurate aminoacylation of tRNA.
Several mechanisms by which the editing sites preferen-
tially recognize the noncognate amino acid have been de-
scribed. In some cases, the determining factor is size. The
editing site of IleRS, for example, can accommodate a
tRNA charged with the noncognate valine, but not if it is
charged with the bigger Leu (Muramatsu et al. 1990). In
fact, artificially enlarging the editing site allows leucyl-
tRNAIle to be edited (Hendrickson et al. 2002). A similar
mechanism has been established for the N2 editing site
in ThrRS. Upon aminoacylation, the 3′ end of the tRNA har-
boring the amino acid undergoes a conformational
change and moves from the active site to the N2 editing
site, located 39 Å away from the catalytic site. The editing
activity of ThrRS is directed toward eliminating the non-
cognate Ser-tRNAThr, while editing of the cognate Thr
must be prevented. The editing site architecture is a nar-
row pocket which is able to accommodate serine but not
the bulkier threonine, as the methyl group clashes with
the side chains of the amino acids at the editing site
(Torres-Larios et al. 2002). In other cases, noncognate aa-
tRNA editing is triggered by specific interactions with res-
idues from the editing site. In PheRS, for example, the hy-
droxyl group present in the noncognate tyrosine interacts
with residues of the editing site present in the β-subunit. As
was mentioned before, release of the aa-tRNA is the limit-
ing factor in class I synthetases, which make it possible for
the tRNA to remain bound to the enzyme long enough for
it to be edited. For class II synthetases, which rapidly re-
lease the product, these enzymes seem to be able to re-
capture the liberated misacylated tRNA. For example,
PheRS is able to compete with EF-Tu and recapture and
then edit Tyr-tRNAPhe (Ling et al. 2007).
Editing factors
Another important component of the translation quality
control machinery is the trans-editing family, freestanding
proteins that are not synthetases but are in some cases ho-
mologs to the editing domains of such enzymes. The role
of these trans-editing factors is to clear the misacylated
tRNA before it reaches the ribosome, acting as additional
checkpoints to ensure fidelity. In some archaeal genomes,
the thrS gene is shortened and, as a result, the ThrRS en-
coded by it lacks the amino-terminal domain usually re-
sponsible for editing. This function is carried out by a
freestanding protein termed ThrRS-ed, a structural homo-
log to the DTDs mentioned above (Beebe et al. 2004;
Korencic et al. 2004; Dwivedi et al. 2005; Hussain et al.
2006; Shimizu et al. 2009). AlaX proteins can be found in
the three kingdoms of life and are homologs to the editing
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domain of AlaRS (Chong et al. 2008). While AlaRS possess-
es editing activity against both Gly-tRNAAla and Ser-
tRNAAla, AlaX activity is exclusive to Ser-tRNAAla. This ap-
parent redundancy in activities highlights the enormous
evolutionary pressure to prevent Ser misincorporation
(Schimmel 2011). The INS superfamily are proteins homo-
logs to the INS editing domain of ProRS with editing activ-
ity directed toward mischarged tRNAPro. Examples of
members of this family are the proteins ProXp-ala and
Ybak which are responsible for editing Ala-tRNAPro
and Cys-tRNAPro, respectively. Although ProXp-ala (An
and Musier-Forsyth 2004) is able to bind tRNA by interac-
tion with the acceptor stem, Ybak requires binding to
ProRS. Recently, the editing factors ProXp-ST1 and ProXp-
ST2 were identified that edit tRNAs misacylated with Ser
or Thr by several synthetases such as ThrRS, AlaRS, IleRS,
LysRS, and ValRS (Liu et al. 2015; Chen et al. 2019).
Another family of trans-editing factors are the d-amino-
acyl-tRNA-deacylases (DTDs), a set of trans-editing factors
that specifically target tRNAs charged with D-forms of ami-
no acids. Although the structure of the active site in synthe-
tases can bind D-amino acids, it usually imposes a physical
constraint that does not promote tRNA charging. In the
cases in which D-amino acids are charged, their use in
the ribosome must be prevented, as their introduction
into the polypeptide chain may alter the three-dimension-
al structure of a protein. To date, two types of DTD are
known with similar functions with subtle changes in se-
quences and possess a characteristic amino acid signature
“SQFT” for DTD1 or “PQAT” for DTD2 (Wydau et al.
2009). In addition to editing D-amino acids, DTDs have
also been shown to be able to hydrolyze the achiral glycine
and edit Gly-tRNAAla (Pawar et al. 2017) while preventing
editing of the cognate Gly-tRNAGly via a conserved dis-
criminator base at position 73 (Kuncha et al. 2018).
Substrate specificity and editing
Editing activity is not a requirement for all synthetases and,
in fact, only about half of them possess this activity. In
many instances, the high specificity of the active site is
enough to circumvent the need for proofreading and edit-
ing. The overall need for accuracy seems to vary not only
among organisms and can also differ between the analo-
gous organellar and cytoplasmic enzymes. For example,
in eukaryotes the cytosolic PheRS is a heterotetramer com-
posed of 2 α subunits that harbor the active site and 2 β
subunits with editing activity. The mitochondrial counter-
part is only composed of the α subunit and lacks editing,
which raises the question as to how protein synthesis accu-
racy is maintained in mitochondria. Although the mtPheRS
is unable to clear the noncognate Tyr-tRNAPhe, it has been
shown that the enzymes compensate with an enhanced
specificity at the active site. The rate of misactivation of ty-
rosine is kept at a low rate of 1:7300 Phe:Tyr, compatible
with an error rate in translation of 10−4 (Reynolds et al.
2010b). The need for this activity is dependent on the rel-
ative affinity for the cognate and noncognate amino acid.
A very informative factor for evaluating the need for edit-
ing activity is the specificity coefficient, defined as the ratio
of the catalytic efficiency (kcat/KM) for the cognate over the
noncognate substrate. In aaRSs where this value is over
3000, themisincorporation of amino acid is assumed to oc-
cur at such a low level that it has no impact on cell fitness
and editing activity is not needed (Fersht 1977;
Mascarenhas et al. 2008; Reynolds et al. 2010a).
AaRSs AND MISTRANSLATION
Although it is estimated that a cell is able to tolerate a mis-
coding event every 103–104 codons translated without
compromising fitness (Yu et al. 2009), misincorporation
of amino acids can lead to inactive or misfolded proteins,
whose accumulation is associated with several patholo-
gies. One such pathology is neurodegeneration, an abnor-
mality that has been extensively studied in connection with
mouse AlaRS. AlaRS is potentially able to facilitate misin-
corporation of Gly and Ser and prevents such errors with
an editing domain at the carboxyl terminus that clears non-
cognate aa-tRNAs (Tsui and Fersht 1981; Beebe et al.
2003). In the mouse model, a missensemutation in this ed-
iting domain impairs editing activity and causes accumula-
tion of mischarged tRNAAla in Purkinje cells, a population
of neurons found in the cerebellum, leading to synthesis
of misfolded proteins, triggering the activation of the un-
folded protein response and, in turn, degeneration and
cell death. Damage to the Purkinje cells in themousemod-
el provokes tremors, ataxia and impaired balanced (Lee
et al. 2006).
AlaRS faces a unique challenge when maintaining fidel-
ity as it is able to activate not only the smaller Gly but also
the bigger Ser. Structural studies of AlaRS have shown that
misactivation of serine is not a result of the activation pock-
et size but due to an interaction of the hydroxyl group of
the serine with a conserved aspartate residue (Asp235 in
E. coli) in the active site that is essential to hold the α-amino
group of the cognate alanine (Guo et al. 2009). The partic-
ular architecture of the active site of AlaRS imposes an un-
avoidable constraint that makes activation of serine
impossible to prevent. To avoid use of the noncognate
Ser-tRNAAla in protein synthesis, an additional checkpoint
has evolved, the aforementioned trans-editing factor
AlaX/AlaXps, the activity of which is mainly focused
against serine, and is also occasionally directed against
Gly-tRNAAla. Recently, an additional mechanism prevent-
ing Ser-to-Ala misincorporation has been described in
the ANKRD16 protein. ANKRD16 is a vertebrate-specific,
ankyrin repeat-containing protein that binds to the catalyt-
ic domain of AlaRS and is able to remove the misactivated
serine in a tRNA-independent manner, incorporating the
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serine into ANKRD16 (Vo et al. 2018). The role that
ANKRD16 plays in preventing serine mistranslation has
not been described before for any synthetase, and al-
though it may be tentatively classified as a trans-editing
factor (or perhaps more accurately, cofactor) it represents
a new layer of proofreading whose importance for limiting
other synthetase aminoacylation is currently completely
unknown.
While mistranslation is generally detrimental to viability,
there are instances in which misincorporation of amino ac-
ids may actually provide a selective advantage under cer-
tain stress conditions (Pan 2013; Ribas de Pouplana et al.
2014). For example, MetRS has been shown to mismethio-
nylate tRNAs inmammalian and yeast cells under oxidative
stress conditions. Surface residues substituted with methi-
onine could potentially neutralize the highly reactive spe-
cies produced under oxidative stress, preventing the
oxidation of sensitive amino acid chains at the active site
that would result in permanent inactivation of the enzyme.
The methionine-substituted residues would work as a sink
for ROS without excessively compromising the folding of
the protein (Netzer et al. 2009; Jones et al. 2011;
Wiltrout et al. 2012). In Mycobacteria, errors in protein
translation can promote the development of phenotypic
resistance against the antibiotic rifampicin (Javid et al.
2014).
Maintaining andmodulating accurate charging of tRNAs
has important roles beyond its immediate impact on the fi-
delity of translation. The charging levels of tRNAs are used
by cells to sense the available amino acid pool. Under ami-
no acid starvation, uncharged tRNA accumulates in cells.
In bacteria this deacylated tRNA enters the A site of the ri-
bosome, the ribosome pauses as it is unable to proceed
with translation and transfers the tRNA to RelA, which trig-
gers production of (p)ppGpp, an alarmone that activates
the stringent response in bacteria (Cashel 1969, 1975;
Barker et al. 2001; Paul et al. 2004; Agirrezabala and
Frank 2010; Arenz et al. 2016). During the stringent re-
sponse, deep changes in translation, activation of tran-
scription of amino acid synthesis genes and arrest of
growth occurs, among other changes (Gallant et al.
1971; Rojas et al. 1984; Kanjee et al. 2011; Zhang et al.
2018). A deficient editing function canmask the real amino
acid levels, as mischarged tRNAs do not activate the strin-
gent response. For example, in E. coli mutants where the
PheRS editing activity has been ablated, addition of the
noncognate m-Tyr delays the onset of the stringent re-
sponse. It has been proposed that this delay allows for ad-
ditional rounds of cell growth and division, which may be
advantageous to a subpopulation of cells (Bullwinkle
et al. 2014b). A similar mechanism has been described in
yeast, involving the general amino acid control (GAAC)
pathway. Under amino acid starvation, deacylated tRNA
interacts with the protein kinase general control nonde-
pressible 2 (Gcn2p), activating a cascade that increases
the expression of over 400 genes, decreasing translation
and activating amino acid biosynthesis genes. Similar to
bacteria, errors in the editing activity of PheRS lead to
the accumulation of mischarged m-Tyr-tRNAPhe and pre-
vent accurate sensing of Phe starvation by the GAAC
(Mohler et al. 2017).
Even though proofreading and editing are widely dis-
tributed in all three kingdoms of life, there are also exam-
ples where they have been lost during evolution. A recent
study in Microsporidia, eukaryotic pathogens with the
smallest knowngenome in eukaryotes, revealed synthetas-
es that are shorter than their homologs from other eukary-
otes. In several cases, these 40–300-aa-long deletions
correspond to appended domains to the synthetases
known to be involved in a diverse array of functions such
as tRNA binding or catalytic efficiency or translation unre-
lated activities, such as the assembly of theMSC.One such
deletion affects the editing domain of LeuRS, corrupting
its proof-reading ability. As a result, misincorporation of
Ile, Val, Met, the nonproteinogenic norvaline and several
other amino acids were detected at Leu codons in proteo-
mic analyses, accounting for up 5.9% of Leu codon mis-
sense translation (Melnikov et al. 2018a). Similarly,
bacteria from the genus Mycoplasma have degenerate
and inactive editing domains for ThrRS, PheRS and
LeuRS and frequently exhibit noncognate amino acid in-
corporation in their proteomes (Li et al. 2011; Yadavalli
and Ibba 2012b). Interestingly, although it is possible to
findMycoplasma genomes where two of these synthetase
editing activities are missing no examples are known
where three or more enzymes have lost their editing func-
tion, suggesting that there is an upper limit to tolerance for
mistranslation. In the human fungal pathogen Candida,
the identity of the CUG codon shifted from the canonical
Leu to Ser. Because this tRNA has identity elements from
both LeuRS and SerRS, the editing activity of LeuRS is un-
able to hydrolyze Leu-tRNASer. The ambiguous decoding
can result in up to 5% of leucinemisincorporation at Ser co-
dons (Gomes et al. 2007; Silva et al. 2007).
The high level of tolerance to misincorporation exhibit-
ed by some organisms is the subject of intense studies.
All the examples covered above are organisms with at
least partially, parasitic lifestyles, which has led several au-
thors to propose that misincorporation may increase phe-
notypic diversity, increasing the variability of protein
synthesis. The resulting exponential expansion of the pro-
teome could offer advantages against the immune sys-
tem’s defenses, which strongly rely on polypeptide
presentation through the mayor histocompatibility com-
plex (MHC) to detect pathogens (Miranda et al. 2013).
This hypothesis is further strengthened upon extending
the analysis to bacterial genomes, where phylogenetic
analysis revealed that organisms with small genomes usu-
ally contain synthetases with mutated or degenerated ed-
iting sites. These bacteria possess highly reduced
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genomes and are either host-restricted or intracellular par-
asites (Melnikov et al. 2018b). The term statistical prote-
ome has been coined to refer to those instances of
organisms with such intrinsic variability although its impact
on cell viability and pathogenesis remains to be elucidated
(Gomes et al. 2007; Li et al. 2011).
ROLES OF AMINOACYL-tRNA SYNTHETASES
BEYOND TRANSLATION
In the decades after their initial discovery, the synthases
were extensively characterized and their roles in tRNA
charging analyzed in great detail. During that time, it has
become clear that synthetases also exert a myriad of func-
tions outside their classical role in tRNA charging, which is
often referred to as “moonlighting.” Characterization of
these functions outside translation is one of the fastest
growing subfields of synthetase studies and, to date, there
is evidence that synthetases participate in a plethora of dif-
ferent functions, ranging from gene regulators to biosyn-
thetic activities, from intron splicing to angiogenesis (Guo
et al. 2010; Pang et al. 2014; Mirande 2017; Yakobov
et al. 2018). In hindsight, it may have been expected for
these ancient enzymes to have diversified to exert so
many functions, as the properties of their catalytic core,
that is, the ability to bind nucleic acids in a highly specific
mode and to efficiently discriminate chemical groups,
along with their modular nature and the propensity to ac-
quire extra domainsmake these enzymes an extremely ver-
satile scaffold (Pang et al. 2014).
Perhaps the most straightforward examples of the func-
tions of synthetases outside translation are those based on
their ability to recognize the specific sequences of a tRNA.
Participation of aaRSs in transcription or translation pro-
cess is often achieved via hairpins and loops in the nucleic
acid sequence that folds into cloverleaf-like structures that
mimics those of the tRNA substrate. For example, E. coli
ThrRS acts as a transcriptional regulator by repressing
the translation of its own mRNA, which contains a region
upstream of the Shine–Dalgarno sequence that forms
two stems loops that mimic the tRNAThr anticodon arm
and prompt ThrRS binding. These two stem loops contain
both the anticodon CGU and two G and U conserved res-
idues that act as identity elements for tRNAThr (Springer
et al. 1988, 1989). Upon binding, the mRNA is captured
by the enzyme, whose amino terminus clashes with the
platform of the S30 subunit and prevents formation of
the preinitiation complex while ThrRS is bound (Torres-
Larios et al. 2002). Consistent with this model, deletion
of the amino-terminal region abolishes the regulatory
functions of ThrRS (Caillet et al. 2003). The competition
for ThrRS between tRNAThr and the mimic leader se-
quence of the mRNA establish a regulatory feedback
loop that matches ThrRS levels to the availability of
tRNAThr. These stem loops resemble tRNAThr so faithfully,
that switching the anticodon mimicry from threonine to
methionine is sufficient to change the operator to MetRS
(Brunel et al. 1993). It has also been reported that in verte-
brates, ThrRS has aquired a role in translation initiation, via
its unique N-terminal extension that allows the enzyme to
form a complex with 4EHP protein and recruit the initiation
factor eIF4A (Jeong et al. 2019).
A similar model has been proposed for AspRS regula-
tion in S. cerevisiae, in which themRNA for AspRS contains
in its upstream region two structured domains that display
a tRNAAsp anticodon-like stem–loop structure and a dou-
ble-stranded helix (Ryckelynck et al. 2005b). In this model,
two monomers of AspRS recognize and bind these tRNA-
like structures, reducing the translation of mRNA and
therefore regulating levels of AspRS (Ryckelynck et al.
2005a). As in the case of ThrRS, exploiting the ability of
synthetases to bind tRNA-like structures provides a strat-
egy successfully used by both prokaryotes and eukaryotes.
In fungi, TyrRS and LeuRS can participate in intron splic-
ing by interacting with structural motifs similar to tRNAs
(Mohr et al. 2001). In the fungi Neurospora crassa, the mi-
tochondrial TyrRS has been shown to be involved in class I
intron processing (Akins and Lambowitz 1987) via a spe-
cialized amino-terminal domain (Kittle et al. 1991).
Although it was initially thought that the intron would
adopt a tRNA-like folded structure, attempts to crystalize
the complex have shown that the enzyme serves as a scaf-
fold for the RNA, that binds both monomers of the synthe-
tases across an RNA-binding surface different from that
which binds tRNATyr (Paukstelis et al. 2008). A similar splic-
ing activity has also been described for the mtTyrRS of the
Pezizomycotina fungi (Lamech et al. 2016) as well as in the
yeast mitochondrial LeuRS (Houman et al. 2000).
In several instances, paralogs of synthetases take part in
diverse activities, such as HisZ, a paralog of HisRS that is in-
volved in the first step of histidine biosynthesis. YadB is a
paralog of GluRS that attaches a glutamate to a queuosine
modification (Salazar et al. 2003). Synthetases are also in-
volved in regulation of nonsynthetases genes. One ele-
gant model has been described in the yeast
S. cerevisieae, in which the cytosolic MetRS and GluRS
are found in a complex held together by the anchor pro-
tein Arc1p. Upon switching from fermentation to respira-
tion, the Snf1/4 glucose sensing pathway is activated
and expression of Arc1p is severely reduced, which
prompts the release of free cytosolic MetRS and GluRS
(Frechin et al. 2014). After being released, the cytosolic
GluRS is imported to the mitochondria where it generates
the noncanonical Glu-tRNAGln, which is subsequently con-
verted to Gln-tRNAGln by the mitochondrial amidotransfer-
ase, GatFAB, becoming the sole source of Gln-tRNAGln in
the mitochondria (Frechin et al. 2009, 2010). At the same
time, release of MetRS from the dissociated complex un-
masks a nuclear localization signal and MetRS is therefore
imported to the nucleus where it induces the expression of
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Atp1 subunit of the F1 domain of the ATP synthase, which is
later exported into themitochondria. The rest of the compo-
nents are synthesized within themitochondria, using the es-
sential Gln-tRNAGln produced by the cytosolic GluRS. The
concerted activities of the synthetases result in a coordinat-
ed expression of the components of the respiratory chain
from two completely different organelles (Frechin et al.
2014). In eukaryotes, several regulatory functions have
beendescribed,but as almost half the synthases are forming
part of the multisynthetase complex, those functions will be
addressed briefly in the next section. All the examples pro-
vided above offer glimpses of the plethora of functions be-
yond translation that synthetases areoften involvedwith and
the reader is directed to addtional comprehensive reviews
for further information (e.g., Pang et al. 2014).
THE MULTISYNTHETASE COMPLEX
In bacteria, aaRSs are usually freestanding proteins, while
in some Archaea associations between synthetases have
been reported, usually comprising two or three synthetas-
es working in a concerted manner. In the archaeon
Methanothermobacter thermoautothrophicus, LysRS and
ProRS anchor to the idiosyncratic amino- and carboxyl ter-
mini of LeuRS respectively, forming a synthesase complex
alongside elongation factor 1A that enhances aminoacyla-
tion activity of both ProRS and LysRS (Praetorius-Ibba et al.
2007; Hausmann and Ibba 2008). A partnership between
ArgRS and SerRS has also been reported in that same or-
ganism, where it enhances the catalytic activity of SerRS,
especially under conditions of elevated temperature and
osmolarity (Godinic-Mikulcic et al. 2011).
In Eukarya, it is common for synthetases to assemble
along with several accessory proteins into a macromolecu-
lar complex termed the multisynthetase complex (MSC)
(Mirande et al. 1985; Kerjan et al. 1994; Han et al. 2003).
The size and composition of the MSC vary depending on
the organism. In the yeast Saccharomyces cerevisiae, the
MSC is comprised of MetRS, GluRS and the auxiliary pro-
tein Arcp1 while in mammals there exists a large complex
consisting of nine synthetases: Gln, Pro-Glu (in humans,
ProRS, and GluRS are fused via a WHEP domain
(Cerini et al. 1991), Ile, Leu, Met, Lys, Arg, and Asp and
three nonenzyme components, the accessory interacting
multifunctional proteins (AIMPs) 1-3 (Fig. 4). This striking
difference in size and composition suggest an evolutionary
link between the MSC expansion and the increased com-
plexity of the interaction network of their components.
Although the exact function of the MSC remains to be elu-
cidated, it has been proposed that the association of differ-
ent synthetases helps with the channeling of the amino
acid substrate to the tRNA and further delivery to the ribo-
somal machinery (Kyriacou and Deutscher 2008). For ex-
ample, it is known that AIMP3, which is specifically
bound to MRS, relays the methionylated initiator tRNA to
the initiator complex (Kang et al. 2012). One aspect that
is fundamentally clear is that in addition to the canonical
tRNA charging activity, the MSC components are involved
in several fundamental processes outside of translation
such as transcription, cell-signaling and tumorigenesis
(Hyeon et al. 2019). For example, it has been shown that
LeuRS interacts with the Target of Rapamycin (TOR) path-
way, a highly conserved metabolic pathway involved in
regulation of several key processes such as energy metab-
olism, protein synthesis, nutrient uptake or autophagy. In
humans, LeuRS acts as an intracellular leucine sensor, act-
ing as an activator of the mTORC1 complex (Bonfils et al.
2012; Durán and Hall 2012; Han et al. 2012).The overall ar-
chitecture of the MSC has not yet been resolved, although
some structures of subcomplexes have been crystalized
(Norcum and Warrington 1998; Norcum 1999; Wolfe
et al. 2005; Cho et al. 2015). The intricate architecture of
the MSC is held together by a variety of domains append-
ed to the synthetases as well as structural proteins. For in-
stance, GST-homology domains are found inserted in Pro-
GluRS, MetRS and AIMP 2 and 3 while WHEP domains are
inserted in Pro-GluRS and MetRS. Leucine zipper motifs as
well as helical motifs are found at the amino terminus of
LysRS, ArgRS, and LeuRS as well as the AIMP proteins.
All these motifs form a complex web of interactions that
hold together all the elements. The auxiliary proteins
AIMP 1–3 function as a scaffold to bind the synthetases
and are fundamental for the assembly of the MSC and
are essential for the complex to form (Shalak et al. 2001;
Han et al. 2003; Mirande 2017). Deletion of AIMP2 triggers
the disintegration of the complex and is associated with
DNA damage and lethality (Han et al. 2008). Although it
is crucial for the components to stay assembled, under cer-
tain conditions such as under stress, some of the members
A B
FIGURE 4. The multisynthetase complex. Schematic representation
of themultisynthetase complex showing the differences of complexity
between mammalian (A) and yeast (B). Mammalian MSC is a massive
complex composed of nine synthetases and three accessory proteins,
while the yeast counterpart is composed of two synthetases and a
connecting protein. For the sake of simplicity, interactions are not
shown; neither is the possible homodimerization of some of the com-
ponents. The spatial arrangements and sizes of the components do
not necessarily reflect their relative positions in the complexes.
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dissociate from the MSC and can perform other functions.
AIMP3, for example, is usually bound to MetRS and serves
as a conduit for the passage of the methionine-charged
tRNA to initiation complex. Under DNA damage, however,
GCN2 kinase phosphorylates MetRS, inducing a confor-
mational change that forces the ejection of AIMP3, that
is then mobilized to the nucleus and activates p53, activat-
ing DNA replication and repair processes. These auxiliary
proteins are also involved in several diseases in ways that
are still unclear, while AIMP2 exerts a potent antitumori-
genesis activity through interaction with TGF-β, TNF-α,
and p53 (Yum et al. 2016).
AaRSs IN DISEASE
While the changes in the integrity of the MSC plays pivotal
roles in several diseases, the synthetases have direct and
wide-ranging central roles in an ever-increasing number
of pathologies. One example is EPRS, which has been im-
plicated, among other things, in adiposity, antiviral immu-
nity and inflammation (Jia et al. 2008; Arif and Fox 2017).
EPRS is phosphorylated at two serines located in the
noncatalytic segment connecting both active sites upon
activation by IFN-gamma (Arif et al. 2009). The phosphor-
ylation causes EPRS to dissociate from the complex and
bind three other proteins to form the cytosolic IFN-γ-acti-
vated inhibitor of translation (GAIT) complex, that silences
translation of several genes involved in inflammatory pro-
cesses (Arif et al. 2009).
Several synthetases other than EPRS, especially those in
higher vertebrates, also have functions that extend beyond
their essential role in translation, making the study of dis-
ease-associated mutations of aaRS quite a challenging
endeavor. One of the best studied examples is Charcot–
Marie–Tooth disease, a neurodegenerative disease in
humans that is associated with a wide spectrum of neurop-
athies. Numerous genetic mutations are associated with
CMT and, interestingly, these mutations are found in sev-
eral aaRSs (for reviews, see Boczonadi et al. 2018; Wei
et al. 2019), among which are the genes for GlyRS
(Antonellis et al. 2003), TyrRS (Jordanova et al. 2006;
Blocquel et al. 2017), LeuRS or AlaRS (Latour et al. 2010).
An increasing body of results has also uncovered links
with cancer, with almost half the synthetases connected
directly or indirectly with cancer (for review, see Kim
et al. 2013). For example, LysRS promotes anabolic cellular
processes and growth regulating the mTORC1 pathway
(Han et al. 2012), while ThrRS can be secreted by apoptotic
cells and plays a role in angiogenesis (Arif et al. 2009).
Other examples are the implication of LeuRS and MetRS
in tumor formation or cell death induced by TrpRS (Shin
et al. 2008; Lukk et al. 2010). In addition, other elements
related to aaRSs, such as tRNA biogenesis, modification,
elongation factors and ribosome biosynthesis are also im-
plicated in several diseases (Tahmasebi et al. 2018) and
synthetases have also been shown to play a role in MYC-
driven growth (Zirin et al. 2019). Another potential connec-
tion between aaRSs and diseases comes with the recent
finding that regulation of tRNA levels regulates the synthe-
sis of tRNA-derived fragments (Torres et al. 2019). Another
excellent example comes from the interplay between
LysRS and the HIV-1 Gag polyprotein. During viral infec-
tion, HIV requires human tRNALys as a primer for reserve
transcription of genomic RNA to DNA, which is then pack-
aged into the virus alongside human LysRS during viral as-
sembly (Jiang et al. 1993; Cen et al. 2001; Musier-Forsyth
2019). Although several of the details are still unknown, it
has been proposed that the Gag protein is able to capture
newly synthetized LysRS before its assembly into the MSC
(Guo et al. 2003; Halwani et al. 2004).
As mentioned above, eukaryotic organelles have their
own sets of synthetases and tRNAs. Mutations in mito-
chondrial aaRSs disrupt the respiratory chain. These are
the cause of multisystemic disorders such as encephalop-
athy, cardiomyopathy or sideroblastic anaemia, diseases
that are fatal. While the main function of the mitochondria
is to provide ATP, it is unclear how mutations in mitochon-
drial aaRSs can give rise to such a wide-ranging set of dis-
eases, which include a large spectrum of clinical
presentations, particularly muscular and neurological dis-
orders, although the clinical manifestation seems to be re-
lated to the particular nature of the tissue. A considerable
body of clinical and experimental data related to aaRS and
tRNA-related mitochondrial myopathies has been gener-
ated over the last few years, and consistent themes are
now starting to emerge although direct correlations be-
tween mutations, functional changes, and disease pheno-
types remain elusive in many cases (González-Serrano
et al. 2019;Wei et al. 2019). The roles of tRNAs and synthe-
tases in health and disease will undoutebdly continue to
expand, and are the subject of a series of recent thematic
reviews (Musier-Forsyth 2019).
DRUG DESIGN AGAINST aaRSs
Disruption of protein synthesis is an extremely widespread
and effective strategy for development of antimicrobial
drugs (Kohanski et al. 2010; Wilson 2014) and several of
the most used antibiotics today specifically target ribo-
somal protein synthesis. Avoiding cross reaction of the an-
tibiotic with the human protein synthesis machinery is a
pivotal step in developing an effecting drug, a step which
is eased while targeting the ribosome, as a result of the
abundant structural differences between the 70S bacterial
and 80S eukariotical ribosomes.
Due to their central role in protein synthesis, aminoacyl-
tRNA synthetases have also garnered interest as potential
antimicrobial targets. The abundance of structural and bio-
chemical data for aaRSs has highlighted the evolutionary
divergence between bacterial, archaeal and eukaryotic
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enzymes. The fact that aaRS presents three distinct sites for
their substrates (plus the editing site in some cases) and
that rely on very specific contacts for tRNA binding provide
multiple avenues that can be exploited to abort tRNA
charging. Comparison between sequences of aaRSs for
the three domains of life revealed an early divergence in
nine syntethases (PheRS, TyrRS, LeuRS, IleRS, GluRS,
TrpRS, HisRS, ProRS, and AspRS) between bacterial and ar-
chaeal variants, with further divergence of the eukaryotic
lineage, a phenomenon termed “full canonical pattern”
(O’Donoghue and Luthey-Schulten 2003). Two particularly
promising targets are GlyRS and PheRS, as the prokaryotic
and eukaryotic variants exhibit prominent divergence, es-
pecially regarding quaternary structure. In addition, the
fact that most synthetases in humans are locked into the
MSC can make them less accessible to certain drugs.
Because the catalytic core of the aaRS is the most con-
served sequence, design is often turned to the accessory
sites such as the amino acid, ATP or tRNA binding pockets
or the anticodon binding domain. One example of this is
borrelidin, an experimental antimicrobial drug that inhibits
ThrRS by interacting with all the amino acid, tRNA and ad-
enylatebinding sites, in adittion to a fourth binding site that
is not required for substrate binding (Fang et al. 2015).
Borrelidin has also been shown to exhibit antitumoral prop-
erties by inducing apoptosis of tumoral cells in leukemia
(Habibi et al. 2012) as well as showing very promising re-
sults as an antimalarial drug (Azcárate et al. 2013).
Most of the inhibitors developed so far act as a non-
cleavable analog of the aminoacyl-tRNA. One of the best
studied cases is muropicin, a broad-spectrum antibiotic
that functions as an uncleaveablemimic of isoleucyl-adeni-
late and specifically inhibits eubacterial and archaeal syn-
thetases (Hughes and Mellows 1980; Silvian et al. 1999).
Interestingly, muropicin binds E. coli IleRS with over
8000-fold more strongly than rat IleRS despite only differ-
ing in two amino acids at the catalytic site (Nakama et al.
2001). The antiprotozoal halofuginone works in a similar
fashion, mimicking both proline and tRNAPro in the active
site (Zhou 2013) as is the case with phenyl-thiazolylurea-
sulfonamides, that occupies the tRNA binding pocket of
PheRS, inhibiting its activity (Abibi et al. 2014). On the oth-
er hand, agents such as pentamidine and purpuromycin
have been described to inhibit different synthetases via
nonspecific tRNA binding mechanisms (Kirillov et al.
1997; Sun and Zhang 2008). Another potential, yet largely
unexplored, target is the editing site of the synthetases. As
has been discussed above, some organisms (especially
pathogens) seem to be able to withstand high levels of
amino acid misincoporation, or even be able to dispense
of the editing function altogether, making the editing a
less promising target. Nevertheless, it has been described
that the compound AN2690 (5-fluoro-1,3-dihydro-1-hy-
droxy-2,1-benzoxaborole, Tavaborole), a broad spectrum
antifungal therapeutic agent, is able to inhibit LeuRS by
trapping the tRNA within the editing site (Rock et al.
2007), forming a stable aduct that halts protein synthesis.
Drug design against aaRSs is steadily shifting from
chemical library testing toward a more directed approach.
As more and more structural and biochemical data are
made available, specific interactions can be targets for
drug design, allowing a more efficient and specific drug
design. Within this framework, it is vital to identify tRNA
determinants and residues involved in substrate binding,
work that is made more difficult due to the still incomplete
databases of tRNA modifications. To make matters worse,
all compounds must be tested to avoid cross reactions not
only with the cytosolic protein synthesis machinery, but
with the mitochondrial one as well (Ho et al. 2018).
Nevertheless, the ever growing list of publications regard-
ing this topic validates aaRSs as an extremely interesting
target for drug design.
EXPANSION OF THE GENETIC CODE AND
ARTIFICIAL AMINOACYL-tRNA SYNTHETASES
Beyond their natural roles, the aaRS have also played a piv-
otal role in synthetic biology, specifically the rewriting of
the genetic code to allow for the incorporation of nonca-
nonical amino acids (ncAAs, also known as nonstandard
amino acids or nsAAs) into proteins. Incorporation of these
engineered proteins into organisms allows an almost end-
less stream of possibilities: creation of biosensors and bio-
markers, incorporation of new chemistries and new protein
functions, advances in the study of protein structure and
function, resistance to virus and horizontal gene transfer
or containment of genetically modified organisms
(Rovner et al. 2015). Successful expansion of the genetic
code requires altering two fundamental steps in transla-
tion, repurposing an aaRS:tRNA pair to incorporate the
ncAA and assigning a codon for this new translation
component.
One of the biggest challenges when engineering an
aaRSs to incorporate ncAAs is the issue of orthogonality,
that is, creating an aaRS - amino acid pair that does not
cross-react with other elements of the decoding machin-
ery. One approach to solve this issue is the transplantation
of an existing aaRS-tRNA pair from another organism. This
is possible if the tRNA determinants for the donor and re-
ceiving species do not match. Exploiting the difference
between tRNA identity elements from different species
represented the first successful attempt to expand the ge-
netic code with TyrRS. In bacteria, tRNATyr identity ele-
ments include a G1-C72 base pair, which are inverted in
archaea and eukaryotes (C1-G72) (Bedouelle 1990;
Himeno et al. 1990; Fechter et al. 2000). Transplanting
the tRNATyr/TyrRS from the archaea Methanocaldococcus
jannaschii to E. coli allow the bacteria to encode an addi-
tional artificial amino acid O-methyl-L-tyrosine (Wang
et al. 2001). Unfortunately, the introduction of this system
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in eukaryotes is not possible, as eukaryotic tRNATyr recog-
nition elements overlap with those of the archaeal tRNATyr
(Fechter et al. 2001).
By nature of their tRNA recognition elements, some
aaRSs are inherently more suitable to become targets of
genetic code expansion, as is the case of SerRS or
LeuRS, whose tRNAs have important recognition elements
situated in the variable arm rather than the anticodon, al-
lowing the introduction of mutated codons without affect-
ing tRNA charging (Park and Schimmel 1988; Dock-
Bregeon et al. 1990a; Asahara et al. 1993). Such is the
case of SerRS and tRNASec in which the tRNA anticodon
can be recoded without affecting aminoacylation, al-
though in this case it requires construction of a tRNASec/
tRNASer hybrid, in which the elements for EF-Tu recogni-
tion from tRNASer are transplanted into tRNASer, to prevent
recognition by the specialized elongation factor SelB
(Miller et al. 2015). The result is a chimeric tRNA that has
been successfully used in developing the engineered
tRNAs tRNAUTu and tRNASecUX. Another pair widely used
is the PylRS-tRNAPyl system, as this amino acid is absent
in most organisms and the distinctive structure of tRNAPyl
and its idiosyncratic recognition elements allows for its in-
troduction into a wide range of organisms (Kavran et al.
2007; Kobayashi et al. 2009; Ho et al. 2016). The
tRNAPyl–PylRS and M. jannaschii tRNATyr–TyrRS systems
—either wild type or engineered—are so popular that
more than two thirds of all the ncAAs incorporated to
date are based on these systems (Melnikov and Söll 2019).
Achieving a robust orthogonality is just the first step in
ncAA incorporation. The next step is the engineering of
the synthetase to be able to activate the ncAA, which
can be achieved by evolving the enzyme using mutagene-
sis strategies via either mutagenic oligos or phages, cou-
pled with selection systems to sort out the candidates
able to aminoacylate the ncAA. Examples of the first strat-
egy include multiplex-automated genome engineering
(MAGE) that is based on the incorporation of mutated oli-
gos into the lagging strand during DNA replication (Wang
et al. 2009; Isaacs et al. 2011). These oligonucleotides are
designed to be complementary to specific regions of the
desired gene (in the case of synthetases, these sites often
include the amino acid or tRNA binding regions) and can
be generated to include random sequences. Strategies
based in phages, such as phage-assisted continuous evo-
lution (PACE), use plasmid-based mutagenesis (Esvelt
et al. 2011) to generate variability.
The final step is to assign a codon for the new ncAA
tRNA/aaRS pair, a challenging task, as all triplet combina-
tions have already been assigned an amino acid. As codon
usage is not the same among all organisms (and, in fact,
some organisms have stopped using certain codons alto-
gether) it is possible to mutate the genome to reassign
the least used codons to synonymous ones, freeing one
triplet to be used for a ncAA. Another widespread strategy
is the repurposing of stop codons, which has been
achieved in E. coli, by replacing all TAG termination co-
dons by TAA and removing release factor 1, providing a
blank TAG codon that can be freely assigned (Isaacs
et al. 2011; Lajoie et al. 2013). A similar approach has
also been successfully used on other microbial genomes
such as Salmonella typhimurium (Lau et al. 2017). This
strategy can be expanded even further, recoding as
much as seven codonswithout affecting cellular fitness sig-
nificantly (Ostrov et al. 2016). Finally, it is also possible to
add unnatural bases or codon quadruplets to make room
in the genetic code for new tRNA-synthetase pairs
(Anderson and Schultz 2003).With the advent of recent ad-
vances in whole genome synthesis, it is becoming possible
to design and engineer whole genomes de novo, fine-
tuned to incorporate all the necessities and constraints to
build an efficient platform for ncAA incorporation. An ex-
ample of this approach can be found in the design of the
synthetic yeast genome Sc2.0, in which all TAG stop co-
dons are changed to TAA and all tRNAs rearranged into
a new chromosome (Mitchell et al. 2017; Richardson
et al. 2017). The rapidly changing field of aaRS synthetic
biology is well-served by a steady stream of comprehen-
sive reviews for the interested reader covering a broad
field of topics; from general overviews (Melnikov and Söll
2019; Smolskaya and Andreev 2019), genetic code expan-
sion (Mukai et al. 2017b; Reynolds et al. 2017; Arranz-
Gibert et al. 2018), adding amino acids with new chemis-
tries (Wang et al. 2009; Liu and Schultz 2010; Sakamoto
et al. 2014) or engineering of tRNA-aaRSs pairs (Mukai
et al. 2017b; Baumann et al. 2018).
CONCLUSION
Since their discovery in the 1960s, our knowledge about
the aminoacyl-tRNA synthetases has expanded substan-
tially. Research has provided information about the differ-
ent strategies that have evolved over time to accurately
perform aaRS function as proteomes grew in diversity
and complexity, as well as provide meaningful insights
on evolution from the LUCA to modern day organisms.
Research on the impact of aaRSs on disease has implicated
these enzymes in a plethora of diseases and provided new
druggable targets and strategies to combat them. More
recently, it has been shown that quality control and faithful
translation have a broader impact beyond just protein syn-
thesis and are involved in other biological processes.
Quality control requirements vary within different organ-
isms, which often must strike a balance between costs
and adaptability, and some parasitic organisms are able
to reduce their quality control to drastically increase their
proteome variability. In recent years, the enzymatic versa-
tility of the aaRSs has also gained considerable attention
with the design of modified synthetases to incorporate ar-
tificial or nonnaturally occurring amino acids for synthetic
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biology applications. Overall, the aaRSs continue to im-
pact more and more areas of molecular biology, belying
the important but very limited role first assigned to them
as the enzymes to charge Crick’s adaptor molecules in
his eponymous adaptor hypothesis.
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